跳至主要内容
临床试验/NCT00214149
NCT00214149终止2 期

A UW Phase II Trial of Multi-catheter HDR Brachytherapy Following Lumpectomy for Early Stage Breast Breast Cancer

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 127 人开始时间: 2004年10月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
入组人数
127
试验地点
2
主要终点
To Determine if Brachytherapy Will Produce Non-inferior Local Regional Control at 5 Years Post Treatment When Compared to Historical Results of Conventional XRT

研究概览

简要总结

Breast conservation therapy (BCT) is now widely accepted as a treatment option for most women with Stage I and II invasive breast cancer and most patients with ductal carcinoma in situ (DCIS). Despite superior cosmetic outcome, BCT is more complex and requires a protracted treatment regimen comprised of 6 weeks of daily external beam radiation therapy to the whole breast. The purpose of this study is to determine if an acceptable outcome can be achieved with radiation delivered only to the region of the tumor bed. If this is true, partial breast irradiation may lend itself to much shorter treatment times (one week) and the toxicities to adjacent normal structures (heart, lung, chest wall) will be greatly reduced.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Invasive breast cancer or DCIS, tumor stage of Tis, T1, T2 if lesion is < 3 cm, N0 or N1 if 1-3 + nodes with no extracapsular extension

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

breast brachytherapy to a dose of 34 Gy

干预措施: brachytherapy (Radiation)

结局指标

主要结局

To Determine if Brachytherapy Will Produce Non-inferior Local Regional Control at 5 Years Post Treatment When Compared to Historical Results of Conventional XRT

时间窗: 5 years

次要结局

  • To Determine if Brachytherapy Will Produce Non-inferior Toxicity to XRT at 3 Years(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验